-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $130 Price Target

Benzinga·07/17/2026 13:02:50
语音播报
RBC Capital analyst Shagun Singh reiterates Abbott Laboratories (NYSE:ABT) with a Outperform and maintains $130 price target.